COVID-19 treatment during and after recovery: What to expect

Ari Fahrial Syam

Abstract


Currently, there are no clinically specific drug for COVID-19, neither novel treatments nor vaccines. Hospitals and researchers over the world are testing many different therapies on coronavirus-positive patients in an effort to find a potential COVID-19 treatment, a few medications that have been making a buzz in the science community such as remdesivir, hydroxychloroquine and chloroquine, favipiravir, oseltamifir, lopinavir/ritonavir, azithromycin, plasma convalescent, dexamethasone and stem cell.


Keywords


remdesivir; choloroquin; plasma convalescent; COVID-19; SARS-Cov2

Full Text:

WNJ.V04.S3.0011


DOI: https://doi.org/10.25220/WNJ.V04.S3.0011

Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Ari Fahrial Syam

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

View My Stats